← FDA Drug Approvals (Drugs@FDA)

TAVABOROLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2020-10-21

Drug application

FDA Application #

ANDA212188

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAVABOROLE

Generic name

TAVABOROLE

Active ingredients

TAVABOROLE

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2020-10-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown